BioSpace News Archive

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer

Oncolytics Biotech® Inc., a leading clinical-stage company specializing in immunotherapy for oncology, will commence enrollment into a new GOBLET study pancreatic cancer cohort following both German regulatory and ethics approvals.

May 9, 2024
·
10 min read
Business

Evogene Schedules First Quarter 2024 Financial Results Release

Evogene Ltd., a leading computational biology company targeting to revolutionize life-science product discovery and development, announced that it will release its financial results for the first quarter of 2024, on Thursday, May 23, 2024.

May 9, 2024
·
2 min read
Business

Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Akebia Therapeutics®, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, reported financial results for the first quarter ended March 31, 2024.

May 9, 2024
·
17 min read
Business

Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis

Danaher Corporation, a global science and technology innovator, launched a collaboration with Johns Hopkins University aiming to develop new methods for diagnosing mild TBI.

May 9, 2024
·
6 min read
Business

Ironwood Pharmaceuticals Reports First Quarter 2024 Results

Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, reported its first quarter 2024 results and recent business performance.

May 9, 2024
·
34 min read
Business

LENSAR Reports First Quarter 2024 Results and Provides Business Update

LENSAR, Inc. today announced financial results for the quarter ended March 31, 2024 and provided an update on key operational initiatives.

May 9, 2024
·
13 min read
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference

ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 1:35 p.m. ET.

May 9, 2024
·
4 min read
Genetown

PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting

PureTech Health plc today announced two poster presentations detailing the results from multiple clinical trials of SPT-300 at the Society of Biological Psychiatry Annual Meeting in Austin, TX.

May 9, 2024
·
10 min read
Lone Star Bio

Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024

Lexicon Pharmaceuticals, Inc. announced its participation in the Bank of America Securities Healthcare Conference 2024. Jeff Wade, Lexicon’s president and chief financial officer, will make a company presentation on Tuesday, May 14, 2024, at 8:00 am PDT.

May 9, 2024
·
2 min read
Business

Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics, Inc., a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, reported operational highlights and financial results for the first quarter ended March 31, 2024.

May 9, 2024
·
15 min read